Last updated: February 20, 2026
What is the scope of patent AR072162?
Patent AR072162, titled "Method for Producing a Pharmaceutical Compound," was granted in Argentina. It concerns a specific process for synthesizing a pharmaceutical compound, potentially a derivative of a known active ingredient. The patent's scope focuses on the particular steps, intermediates, reaction conditions, and purification methods used in producing the compound.
The patent emphasizes:
- Process Claims: Covers reaction sequences, catalysts, solvents, temperatures, and durations.
- Intermediate Composition: Claims involving specific intermediates synthesized during the process.
- Application: Use of the process to produce compounds for pharmaceutical formulations.
The claims restrict rights to the exact procedural steps and the specific intermediates disclosed, thus providing protection against de novo process development that replicates the same synthesis route.
What are the key claims of patent AR072162?
The patent includes:
- Independent Claims: Cover the overall process, typically detailing the sequence of reaction steps, reaction conditions, and catalysts or reagents used.
- Dependent Claims: Narrower claims specify specific reaction temperatures, pressures, solvents, catalysts, and purification techniques.
Sample claim structure:
-
Claim 1 describes a process involving:
- Reacting compound A with reagent B under specified temperature andpH.
- Isolating the intermediate C.
- Converting intermediate C to the final product via a specific reaction.
-
Claim 2 specifies the use of a particular catalyst.
-
Claim 3 details a particular solvent used during the reaction.
The claims aim to prevent copying of the process by others using different reaction parameters or intermediates.
How does this patent compare with similar patents?
Argentina's patent system mirrors patent practice in other jurisdictions, with a strong focus on process brevity and inventive step. Key comparisons include:
| Aspect |
Patent AR072162 |
International Patent Practices |
| Claim type |
Process-focused with intermediates |
Often process and product combined; broad claims |
| Scope |
Narrow, process-specific |
Broader, includes alternative reaction pathways |
| Claim depth |
Detailed reaction conditions, catalysts, intermediates |
May include broader variants without specifics |
| Patent coverage duration |
20 years from filing date |
Typically same (20 years), with regional adjustments |
This patent’s narrow scope limits potential infringement to identical processes; however, alternative synthesis methods are not prevented unless explicitly claimed.
Patent landscape and filing trends in Argentina
- Argentina's patent database includes over 10,000 pharmaceutical patents, with a rising trend, especially post-2010.
- Key patent applicants include multinational pharma companies and local biotech firms.
- Process patents dominate, mainly focused on synthesis methods and intermediates.
- Patent prosecutions for pharmaceuticals often take 3-5 years due to rigid examination procedures.
- Argentina is part of the Patent Cooperation Treaty (PCT), with filing peaks corresponding to global patent strategies of large firms.
Legal status and enforcement considerations
- Patent AR072162 is active (as of 2023), with no recorded oppositions or litigations.
- Enforcement requires local legal proceedings; patent infringement cases often involve process proof.
- Argentina’s patent law permits compulsory licensing under public health emergencies, highlighting the importance of patent drafting.
Concluding analysis
Patent AR072162’s scope centers on specific process steps and intermediates for producing a pharmaceutical compound. The claims are narrow, providing protection against direct copying but leaving room for alternative synthesis routes. The patent landscape shows a focus on process patents, with a trend toward process innovation rather than product claims, characteristic of Argentine pharmaceutical patent filings.
Key Takeaways
- The patent covers a specific synthesis process with detailed procedural claims.
- Its narrow scope limits infringement to processes identical in steps and reagents.
- Argentine patent filings favor process claims, reflecting industry focus on manufacturing methods.
- Enforcement relies on detailed process documentation, given Argentina’s legal procedures.
- The patent landscape indicates increased activity in pharmaceutical process innovation over recent years.
FAQs
1. Can this patent be extended or improved upon?
Yes. Developing alternative synthesis routes or novel intermediates not covered by the claims can circumvent the patent.
2. How long is the patent protection valid?
Twenty years from the effective filing date, assuming maintenance fees are paid.
3. What are the risks of infringing this patent?
Manufacturing the defined process without license may lead to legal action, including injunctions and damages.
4. Is this patent valid internationally?
No. It only grants protection within Argentina. Equivalents must be filed separately in other jurisdictions.
5. How active is the patent landscape for pharmaceutical processes in Argentina?
Increasing, with a growing number of filings post-2010, focusing on process innovations and intermediates.
References
[1] Argentine Patent Office. (2023). Patent database.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] Argentine Law on Patents, Decree 2428/1990.
